| Adimmune |
Subunit Vaccine (spike protein) |
Effective in the neutralization antibody assay. Phase I trials might be conducted in the third quarter of 2020. |
| Medigen Vaccine Biologics |
Subunit Vaccine (spike protein) |
Conducting animal studies |
| United Biomedical |
Synthetic Peptide- based Vaccines |
Animal testing, anticipate entering human trials in the summer. |
| Academia Sinica |
Subunit vaccine, virus-like particle, Live attenuated vaccines, nanoparticle- based vaccine |
Animal testing |
| National Health Research Institutes (NHRI) |
Peptide vaccine |
Enter human trials as early as this autumn |